-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

Raymond James Downgrades AnaptysBio to Market Perform

Benzinga · 01/06/2023 05:25
Raymond James analyst Timur Ivannikov downgrades AnaptysBio (NASDAQ:ANAB) from Outperform to Market Perform.